Literature DB >> 35099302

Current Status and Emerging Options for Automated Insulin Delivery Systems.

Gregory P Forlenza1, Rayhan A Lal2.   

Abstract

Combining technologies including rapid insulin analogs, insulin pumps, continuous glucose monitors, and control algorithms has allowed for the creation of automated insulin delivery (AID) systems. These systems have proven to be the most effective technology for optimizing metabolic control and could hold the key to broadly achieving goal-level glycemic control for people with type 1 diabetes. The use of AID has exploded in the past several years with several options available in the United States and even more in Europe. In this article, we review the largest studies involving these AID systems, and then examine future directions for AID with an emphasis on usability.

Entities:  

Keywords:  Artificial pancreas; Automated insulin delivery; Hybrid closed loop; Type 1 diabetes

Mesh：

Substances：

Year:  2022        PMID： 35099302      PMCID： PMC9131039          DOI： 10.1089/dia.2021.0514

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN： 1520-9156            Impact factor:   7.337


  79 in total

1.  Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications.

Authors:  Irl B Hirsch; Michael Brownlee
Journal:  JAMA       Date:  2010-06-09       Impact factor: 56.272

2.  Mathematical modeling research to support the development of automated insulin-delivery systems.

Authors:  Garry M Steil; Jaques Reifman
Journal:  J Diabetes Sci Technol       Date:  2009-03-01

3.  Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.

Authors:  Roman Hovorka; Janet M Allen; Daniela Elleri; Ludovic J Chassin; Julie Harris; Dongyuan Xing; Craig Kollman; Tomas Hovorka; Anne Mette F Larsen; Marianna Nodale; Alessandra De Palma; Malgorzata E Wilinska; Carlo L Acerini; David B Dunger
Journal:  Lancet       Date:  2010-02-04       Impact factor: 79.321

4.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

5.  Candidate Selection for Hybrid Closed Loop Systems.

Authors:  Gregory P Forlenza; Marc D Breton; Boris P Kovatchev
Journal:  Diabetes Technol Ther       Date:  2021-10-13       Impact factor: 6.118

6.  Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.

Authors:  Satish K Garg; Stuart A Weinzimer; William V Tamborlane; Bruce A Buckingham; Bruce W Bode; Timothy S Bailey; Ronald L Brazg; Jacob Ilany; Robert H Slover; Stacey M Anderson; Richard M Bergenstal; Benyamin Grosman; Anirban Roy; Toni L Cordero; John Shin; Scott W Lee; Francine R Kaufman
Journal:  Diabetes Technol Ther       Date:  2017-01-30       Impact factor: 6.118

7.  Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: Online Survey and Analysis of Self-Reported Clinical Outcomes.

Authors:  Katarina Braune; Shane O'Donnell; Bryan Cleal; Dana Lewis; Adrian Tappe; Ingrid Willaing; Bastian Hauck; Klemens Raile
Journal:  JMIR Mhealth Uhealth       Date:  2019-07-30       Impact factor: 4.773

Review 8.  Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Authors:  Tadej Battelino; Thomas Danne; Richard M Bergenstal; Stephanie A Amiel; Roy Beck; Torben Biester; Emanuele Bosi; Bruce A Buckingham; William T Cefalu; Kelly L Close; Claudio Cobelli; Eyal Dassau; J Hans DeVries; Kim C Donaghue; Klemen Dovc; Francis J Doyle; Satish Garg; George Grunberger; Simon Heller; Lutz Heinemann; Irl B Hirsch; Roman Hovorka; Weiping Jia; Olga Kordonouri; Boris Kovatchev; Aaron Kowalski; Lori Laffel; Brian Levine; Alexander Mayorov; Chantal Mathieu; Helen R Murphy; Revital Nimri; Kirsten Nørgaard; Christopher G Parkin; Eric Renard; David Rodbard; Banshi Saboo; Desmond Schatz; Keaton Stoner; Tatsuiko Urakami; Stuart A Weinzimer; Moshe Phillip
Journal:  Diabetes Care       Date:  2019-06-08       Impact factor: 19.112

9.  Fast-Acting Insulin Aspart Use with the MiniMedTM 670G System.

Authors:  Liana Hsu; Bruce Buckingham; Marina Basina; Laya Ekhlaspour; Rie von Eyben; Justin Wang; Rayhan A Lal
Journal:  Diabetes Technol Ther       Date:  2021-01       Impact factor: 6.118

10.  Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.

Authors:  Anders L Carlson; Jennifer L Sherr; Dorothy I Shulman; Satish K Garg; Rodica Pop-Busui; Bruce W Bode; David R Lilenquist; Ron L Brazg; Kevin B Kaiserman; Mark S Kipnes; James R Thrasher; John H Chip Reed; Robert H Slover; Athena Philis-Tsimikas; Mark Christiansen; Benyamin Grosman; Anirban Roy; Melissa Vella; Richard A M Jonkers; Xiaoxiao Chen; John Shin; Toni L Cordero; Scott W Lee; Andrew S Rhinehart; Robert A Vigersky
Journal:  Diabetes Technol Ther       Date:  2021-11-16       Impact factor: 6.118
View more
  3 in total

1.  The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes.

Authors:  Jane Lynch; Lauren G Kanapka; Steven J Russell; Edward R Damiano; Firas H El-Khatib; Katrina J Ruedy; Courtney Balliro; Peter Calhoun; Roy W Beck
Journal:  Diabetes Technol Ther       Date:  2022-10       Impact factor: 7.337

2.  A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes.

Authors:  Roy W Beck; Steven J Russell; Edward R Damiano; Firas H El-Khatib; Katrina J Ruedy; Courtney Balliro; Zoey Li; Peter Calhoun
Journal:  Diabetes Technol Ther       Date:  2022-10       Impact factor: 7.337

3.  Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.

Authors:  Laurel H Messer; Bruce A Buckingham; Fran Cogen; Mark Daniels; Greg Forlenza; Rabab Z Jafri; Nelly Mauras; Andrew Muir; R Paul Wadwa; Perrin C White; Steven J Russell; Edward R Damiano; Firas H El-Khatib; Katrina J Ruedy; Courtney A Balliro; Zoey Li; Martin Chase Marak; Peter Calhoun; Roy W Beck
Journal:  Diabetes Technol Ther       Date:  2022-10       Impact factor: 7.337
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.